STOCK TITAN

HCM IV Acquisition Corp. Unit Form 4 Filings

HACQU NASDAQ

Every Form 4 that HCM IV Acquisition Corp. Unit (HACQU) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow HACQU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HACQU filings page.

Rhea-AI Summary

HCM IV Acquisition Corp. director Michael J. Connor reported an “other” equity transaction involving 25,000 Class B ordinary shares. On February 11, 2026, the company’s sponsor, HCM Investor Holdings IV, LLC, assigned 25,000 Class B shares to Mr. Connor in connection with his appointment to the Board of Directors at a stated price of $0.003 per share.

The Class B ordinary shares are automatically convertible into Class A ordinary shares on a one-for-one basis at the time of the company’s initial business combination, subject to anti-dilution adjustments, and they have no expiration date. These Class B shares may be forfeited under certain circumstances related to Mr. Connor’s continued Board service.

Rhea-AI Summary

HCM IV Acquisition Corp. director Thomas Albert Sapio reported an allocation of 25,000 Class B ordinary shares, assigned to him by the Sponsor under a securities purchase agreement in connection with his appointment to the board. These Class B shares are automatically convertible into Class A ordinary shares on a one-for-one basis at the time of the company’s initial business combination, subject to anti-dilution adjustments, and have no expiration date. The Class B shares are also subject to potential forfeiture under certain circumstances related to Mr. Sapio’s board service.

Rhea-AI Summary

HCM IV Acquisition Corp. reported a Form 4 insider transaction reflecting an "other" change involving 75,000 Class B ordinary shares at $0.003 per share. After this transaction, 8,550,000 Class B ordinary shares were held indirectly.

Footnotes explain that in connection with the initial public offering and the appointments of Michael J. Connor, Richard Donohoe and Thomas Sapio to the Board of Directors, HCM IV Investor Holdings IV, LLC, the sponsor, assigned 25,000 Class B ordinary shares to each of these directors. The Class B ordinary shares are automatically convertible into Class A ordinary shares on a one-for-one basis at the time of the initial business combination, subject to anti-dilution adjustments, and have no expiration date.

The shares are held directly by the sponsor under a subscription agreement dated September 5, 2025. Shawn Matthews, the Chairman and Chief Executive Officer, is the managing member of the sponsor, has sole voting and dispositive control over the shares held by the sponsor, may be deemed the beneficial owner, and disclaims beneficial ownership of securities in which he has no pecuniary interest.

Rhea-AI Summary

HCM IV Acquisition Corp. director Richard Charles Donohoe reported an "other" equity transaction involving 25,000 Class B ordinary shares on February 11, 2026. These shares were assigned to him by the Sponsor in connection with his appointment to the board at a stated price of $0.003 per share, leaving him with 25,000 shares directly held. The Class B ordinary shares are automatically convertible into Class A ordinary shares on a one-for-one basis upon the company’s initial business combination, subject to anti-dilution adjustments and potential forfeiture tied to his board service.